Tranexamic Acid in Traumatic Brain Injury
Recruiting
Phase 3
Interventional Study
Inflammatory Response
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Assiut University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Isolated traumatic brain injury patients (mild or moderate cases)
* GCS \> 8
* non penetrating TBI in 8 hours onset
* Age ≥ 18 years
Exclusion Criteria:
* Patient in cardiac arrest
* Patients with coagulopathies
* Renal failure patients
* pregnancy
* Patient refusal to parti…
Contacts